|Ranibizumab and bevacizumab for neovascular age-related macular degeneration|
CATT Research Group
New England journal of medicine 364 (20), 1897-1908, 2011
|Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results|
DF Martin, MG Maguire, SL Fine, G Ying, GJ Jaffe, JE Grunwald, C Toth, ...
Ophthalmology 119 (7), 1388-1398, 2012
|Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial|
AM Maguire, KA High, A Auricchio, JF Wright, EA Pierce, F Testa, ...
The Lancet 374 (9701), 1597-1605, 2009
|Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration|
F Simonelli, AM Maguire, F Testa, EA Pierce, F Mingozzi, JL Bennicelli, ...
Molecular Therapy 18 (3), 643-650, 2010
|The role of apoptosis in age-related macular degeneration|
JL Dunaief, T Dentchev, GS Ying, AH Milam
Archives of ophthalmology 120 (11), 1435-1442, 2002
|Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration|
W Chen, D Stambolian, AO Edwards, KE Branham, M Othman, ...
Proceedings of the National Academy of Sciences 107 (16), 7401-7406, 2010
|Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials|
JE Grunwald, E Daniel, J Huang, G Ying, MG Maguire, CA Toth, GJ Jaffe, ...
Ophthalmology 121 (1), 150-161, 2014
|AAV2 gene therapy readministration in three adults with congenital blindness|
J Bennett, M Ashtari, J Wellman, KA Marshall, LL Cyckowski, DC Chung, ...
Science translational medicine 4 (120), 120ra15-120ra15, 2012
|Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis|
LS Talman, ER Bisker, DJ Sackel, DA Long Jr, KM Galetta, JN Ratchford, ...
Annals of neurology 67 (6), 749-760, 2010
|Five-year outcomes with anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the Comparison of Age-Related Macular Degeneration …|
MG Maguire, DF Martin, G Ying, GJ Jaffe, E Daniel, JE Grunwald, CA Toth, ...
Ophthalmology 123 (8), 1751-1761, 2016
|Reduced foveolar choroidal blood flow in eyes with increasing AMD severity|
JE Grunwald, TI Metelitsina, JC DuPont, GS Ying, MG Maguire
Investigative ophthalmology & visual science 46 (3), 1033-1038, 2005
|Adherence with topical glaucoma medication monitored electronically: the Travatan Dosing Aid study|
CO Okeke, HA Quigley, HD Jampel, G Ying, RJ Plyler, Y Jiang, ...
Ophthalmology 116 (2), 191-199, 2009
|Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal …|
MJ Tolentino, AJ Brucker, J Fosnot, GS Ying, IH Wu, G Malik, S Wan, ...
Retina 24 (1), 132-138, 2004
|Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration|
G Ying, J Huang, MG Maguire, GJ Jaffe, JE Grunwald, C Toth, E Daniel, ...
Ophthalmology 120 (1), 122-129, 2013
|In vivo human choroidal thickness measurements: evidence for diurnal fluctuations|
JS Brown, DI Flitcroft, G Ying, EL Francis, GF Schmid, GE Quinn, ...
Investigative ophthalmology & visual science 50 (1), 5-12, 2009
|Familial risk of pancreatic cancer|
M Schenk, AG Schwartz, E O'Neal, M Kinnard, JK Greenson, JP Fryzek, ...
Journal of the National Cancer Institute 93 (8), 640-644, 2001
|Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite|
LJ Balcer, ML Baier, JA Cohen, MF Kooijmans, AW Sandrock, ...
Neurology 61 (10), 1367-1373, 2003
|Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials|
JE Grunwald, M Pistilli, G Ying, MG Maguire, E Daniel, DF Martin, ...
Ophthalmology 122 (4), 809-816, 2015
|Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)|
SA Hagstrom, G Ying, GJT Pauer, GM Sturgill-Short, J Huang, ...
Ophthalmology 120 (3), 593-599, 2013
|Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials|
GJ Jaffe, DF Martin, CA Toth, E Daniel, MG Maguire, GS Ying, ...
Ophthalmology 120 (9), 1860-1870, 2013